Alumis Inc. Common Stock

Alumis Inc. Common Stockverified

ALMS

Price:

$8.3

Market Cap:

$866.53M

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California.

Industry

Biotechnology

IPO Date

2021-02-22

Stock Exchange

NASDAQ

Ticker

ALMS

The ROE as of December 2025 (TTM) for Alumis Inc. Common Stock (ALMS) is -75.52%

According to Alumis Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -75.52%. This represents a change of 170.22% compared to the average of -27.95% of the last 4 quarters.

Alumis Inc. Common Stock (ALMS) Historical ROE (quarterly & annually)

How has ALMS ROE performed in the past?

The mean historical ROE of Alumis Inc. Common Stock over the last ten years is -222.13%. The current -75.52% ROE has changed -66.00% with respect to the historical average. Over the past ten years (40 quarters), ALMS's ROE was at its highest in in the June 2025 quarter at 12.22%. The ROE was at its lowest in in the December 2023 quarter at -108.83%.

Quarterly (TTM)
Annual

Average

-222.13%

Median

-124.05%

Minimum

-429.22%

Maximum

-113.12%

Alumis Inc. Common Stock (ALMS) ROE by Quarter and Year

Discovering the peaks and valleys of Alumis Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 246.01%

Maximum Annual ROE = -113.12%

Minimum Annual Increase = -73.65%

Minimum Annual ROE = -429.22%

Quarterly (TTM)
Annual
YearROEChange
2024-113.12%-73.65%
2023-429.22%246.01%

Alumis Inc. Common Stock (ALMS) Average ROE

How has ALMS ROE performed in the past?

The current ROE of Alumis Inc. Common Stock (ALMS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-222.13%

5-year avg

-222.13%

10-year avg

-222.13%

Alumis Inc. Common Stock (ALMS) ROE vs. Peers

How is ALMS’s ROE compared to its peers?

Alumis Inc. Common Stock’s ROE is greater than RAPT Therapeutics, Inc. (-61.81%), greater than Neumora Therapeutics, Inc. Common Stock (-113.81%), less than ADC Therapeutics S.A. (82.24%), greater than Ocugen, Inc. (-255.25%), greater than Eton Pharmaceuticals, Inc. (-27.85%), less than Omeros Corporation (57.33%), greater than Fulcrum Therapeutics, Inc. (-32.17%), greater than Lexicon Pharmaceuticals, Inc. (-83.63%), greater than Bicycle Therapeutics plc (-35.54%), greater than Lineage Cell Therapeutics, Inc. (-119.44%),

Build a custom stock screener for Alumis Inc. Common Stock (ALMS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alumis Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alumis Inc. Common Stock (ALMS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alumis Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Alumis Inc. Common Stock's ROE?

How is the ROE calculated for Alumis Inc. Common Stock (ALMS)?

What is the highest ROE for Alumis Inc. Common Stock (ALMS)?

What is the 3-year average ROE for Alumis Inc. Common Stock (ALMS)?

What is the 5-year average ROE for Alumis Inc. Common Stock (ALMS)?

How does the current ROE for Alumis Inc. Common Stock (ALMS) compare to its historical average?